Page 30 - Read Online
P. 30

Mari et al. Mini-invasive Surg 2024;8:7  https://dx.doi.org/10.20517/2574-1225.2023.103  Page 9 of 10

               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               All procedures performed in studies involving human participants were in accordance with the ethical
               standards of AOU Careggi Hospital and with the 1964 Helsinki Declaration and its later amendments or
               comparable ethical standards. Ethics committee approval was obtained from AOU Careggi Hospital -
               Comitato Area Vasta Centro. The approval has been registered by Regional Ethics Committee for Clinical
               Trials of Tuscany under the code: 16210_OSS. Informed consent was obtained from all individual
               participants included in the study.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2024.

               REFERENCES
               1.       EAU. Renal cell carcinoma. Available from: https://uroweb.org/guidelines/renal-cell-carcinoma. [Last accessed on 30 May 2024].
               2.       Mari A, Di Maida F, Tellini R, et al. Oncologic outcomes in patients treated with endoscopic robot assisted simple enucleation
                   (ERASE) for renal cell carcinoma: results from a tertiary referral center. Eur J Surg Oncol 2019;45:1977-82.  DOI  PubMed
               3.       Pecoraro A, Roussel E, Amparore D, et al. New-onset chronic kidney disease after surgery for localised renal masses in patients with
                   two kidneys and preserved renal function: a contemporary multicentre study. Eur Urol Open Sci 2023;52:100-8.  DOI  PubMed  PMC
               4.       Di Maida F, Campi R, Lane BR, et al. Predictors of positive surgical margins after robot-assisted partial nephrectomy for localized
                   renal tumors: insights from a large multicenter international prospective observational project (the surface-intermediate-base margin
                   score consortium). J Clin Med 2022;11:1765.  DOI  PubMed  PMC
               5.       Grosso AA, Marìn DM, Di Maida F, et al. Robotic partial nephrectomy with en bloc removal of a renal vein thrombus for multiple
                   cT3a renal cell carcinoma lesions. Eur Urol Open Sci 2022;44:33-6.  DOI  PubMed  PMC
               6.       Mari A, Tellini R, Porpiglia F, et al. Perioperative and mid-term oncological and functional outcomes after partial nephrectomy for
                   complex (PADUA score ≥10) renal tumors: a prospective multicenter observational study (the RECORD2 Project). Eur Urol Focus
                   2021;7:1371-9.  DOI  PubMed
               7.       Tellini R, Antonelli A, Tardanico R, et al. Positive surgical margins predict progression-free survival after nephron-sparing surgery for
                   renal cell carcinoma: results from a single center cohort of 459 cases with a minimum follow-up of 5 years. Clin Genitourin Cancer
                   2019;17:e26-31.  DOI  PubMed
               8.       Carbonara U, Simone G, Capitanio U, et al. Robot-assisted partial nephrectomy: 7-year outcomes. Minerva Urol Nephrol
                   2021;73:540-3.  DOI  PubMed
               9.       Antonelli A, Minervini A, Mari A, et al; RECORd Project-LUNA Foundation. TriMatch comparison of the efficacy of FloSeal versus
                   TachoSil versus no hemostatic agents for partial nephrectomy: results from a large multicenter dataset. Int J Urol 2015;22:47-52.  DOI
                   PubMed
               10.      Minervini A, Campi R, Kutikov A, et al. Histopathological validation of the surface-intermediate-base margin score for standardized
                   reporting of resection technique during nephron sparing surgery. J Urol 2015;194:916-22.  DOI
               11.      Minervini A, Carini M, Uzzo RG, Campi R, Smaldone MC, Kutikov A. Standardized reporting of resection technique during nephron-
                   sparing surgery: the surface-intermediate-base margin score. Eur Urol 2014;66:803-5.  DOI  PubMed
               12.      Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB. Updates in the eighth edition of the tumor-node-metastasis
                   staging classification for urologic cancers. Eur Urol 2018;73:560-9.  DOI  PubMed
               13.      Minervini A, Campi R, Sessa F, et al. Positive surgical margins and local recurrence after simple enucleation and standard partial
                   nephrectomy for malignant renal tumors: systematic review of the literature and meta-analysis of prevalence. Minerva Urol Nefrol
                   2017;69:523-38.  DOI  PubMed
               14.      Di Maida F, Campi R, Grosso AA, et al; Collaborators. Prognostic features of upstaged pT3a renal tumors with fat invasion after robot-
                   assisted partial nephrectomy: is it time for a new subclassification? Eur J Surg Oncol 2023;49:862-7.  DOI  PubMed
               15.      Campi R, Grosso AA, Lane BR, et al; SIB International Consortium. Impact of Trifecta definition on rates and predictors of
                   “successful” robotic partial nephrectomy for localized renal masses: results from the Surface-Intermediate-Base Margin Score
                   International Consortium. Minerva Urol Nephrol 2022;74:186-93.  DOI  PubMed
               16.      Minervini A, Campi R, Lane BR, et al. Impact of resection technique on perioperative outcomes and surgical margins after partial
                   nephrectomy for localized renal masses: a prospective multicenter study. J Urol 2020;203:496-504.  DOI  PubMed
   25   26   27   28   29   30   31   32   33   34   35